Curative effects of ziprasidone and aripiprazole at acute stage on patients with drug-naive schizophrenia and their effects on metabolism of these patients
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3760/cma.j.issn.1671-8925.2011.10.022
   		
        
        	
        		- VernacularTitle:齐拉西酮与阿立哌唑对首次治疗的精神分裂症患者急性期疗效及代谢的影响
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Xiao-Li WU
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Ji-Hui WANG
			        		
			        		;
		        		
		        		
		        		
			        		Qin-Ling WEI
			        		
			        		;
		        		
		        		
		        		
			        		Jin-Bei ZHANG
			        		
			        		;
		        		
		        		
		        		
			        		Zhuang NG KA
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. 中山大学附属第三医院
			        		
		        		
	        		
        		 
        	
        	
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Ziprasidone;
			        		
			        		
			        		
				        		Aripiprazole;
			        		
			        		
			        		
				        		Schizophrenia;
			        		
			        		
			        		
				        		Glycolipid metabolism
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			Chinese Journal of Neuromedicine
	            		
	            		 2011;10(10):1058-1062
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	Objective To compare the curative effects ofziprasidone and aripiprazole at acute stage on patients with drug-naive schizophrenia and their effects on metabolism of these patients.Methods Forty-six patients with drug-naive schizophrenia,admitted to our hospital from February 2010 to February 2011,were divided into ziprasidone treatment group (n=24,[165±13.51] mg/d) and aripiprazole treatment group (n=22,[28.86±3.06] mg/d); these patients were given the above treatment for 6 week.The scores of positive and negative syndrome scale (PANSS),body mass index (BMI),insulin resistance index (IRI),and levels of fasting blood glucose (FBG),insulin (INS),C-Peptide (CP),total cholesterol (TC),high density lipoprotein cholesterol (HDL-C),low density lipoprotein cholesterol (LDL-C),triglyceride (TG),apolipoprotein-a (APOA) and apolipoprotein-b (APOB) were obtained before and at the end of treatment.Results At the end of treatment,2 patients (9.1%) were cured,7 (31.8%)achieved obvious improvement,9 (40.9%) achieved improvement,and only 4 (18.2%) did not achieve any improvement in the aripiprazole treatment group.However,at the end of treatment,no patient (0%)was cured,7 (29.2%) achieved obvious improvement,12 (50%) achieved improvement,and 5 (20.8%)did not achieve any improvement in the ziprasidone treatment group.The total scores of PANSS after the treatment in both groups decreased significantly as compared with those before treatment (P<0.05).The BMI ([20.14±2.63] kg/m2) in the ziprasidone treatment group at the end of treatment was obviously increased as compared with that ([19.68±2.76] kg/m2) before treatment (P<0.05).The FBG ([4.38±0.59]mmmol/L) at the end of treatment decreased significantly as compared with those before treatment ([4.79±0.59] mmmol/L),and the BMI ([19.65±2.15] kg/m2) was obviously increased as compared with that before treatment ([19.19±2.28] kg/m2) in the aripiprazole treatment group (P<0.05).The metabolic index in the 2 groups was not significantly different at the end of the treatment (P>0.05).Conclusion Both ziprasidone and olanzapine are effective in the treatment of patients with drug-naive schizophrenia;both of them have mild effects on weight of patients with drug-naive schizophrenia,but no obvious effects on other metabolic indices.